DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...

Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...

Next presentation this afternoon is from DexCom, a leader in developing and commercializing continuous glucose monitoring systems for people with diabetes and I'm sure in the future beyond diabetes.

ORO VALLEY, Ariz. (KGUN) — Managing school and daily routines can be a lot for any young student, but for kindergartener Wyatt, who lives with Type 1 diabetes, having a support system makes all the ...

DexCom Inc. (DXCM) reported strong financial performance for the second quarter of 2025, exceeding both earnings and revenue forecasts. The company’s earnings per share (EPS) came in at $0.48, ...

Mark Andrews glued his eyes on the medicine ball in front of him and his opponent; his body craning in a squatting position. He tensed his body in anticipation for the next rapid-fire command. In one ...

Haupt is a health and wellness editor at TIME. Oura CEO Tom Hale On a Monday morning in late April, Oura CEO Tom Hale was feeling well-rested despite having stayed up later than usual the night before ...

Glucose tracking is a natural part of Oura’s $75 million investment from Dexcom. Glucose tracking is a natural part of Oura’s $75 million investment from Dexcom. is a senior reporter and author of the ...